Table of Contents
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Cell and Gene Therapy Marke"4">
- Market Overview
- Market Dynamics
- Drivers
- Rising prevalence of genetic disorders and cancers
- Expanding applications of CAR-T and stem cell therapies
- Increasing approvals from regulatory agencies
- Advancements in gene editing technologies
- Personalized medicine and precision therapies gaining traction
- Restraints
- High cost of treatment and complex manufacturing processes
- Challenges in long-term safety and efficacy assessments
- Regulatory and ethical concerns surrounding gene modifications
- Opportunities
- Expansion of allogeneic (off-the-shelf) cell therapies
- Integration of AI in gene therapy research and drug development
- Rising demand for regenerative medicine applications
- Growing investments from biotech firms and pharmaceutical giants
- Key Market Trends
- Development of next--viral gene delivery systems
- Increasing focus on combination therapies
- Adoption of decentralized manufacturing models for cell therapy
- Unmet Market Needs
- Industry Speaks
- Pipeline Analysis
- Drivers
"5">
- Market Dynamics
- Global Cell and Gene Therapy Market Size & Forecast (2023-2030), By Therapy Type, USD Million
- Introduction
- Cell Therapy
- Gene Therapy
- Global Cell and Gene Therapy Market Size & Forecast (2023-2030), By Indication, USD Million
- Introduction
- Oncology
- Autoimmune Diseases
- Neurological Diseases
- Cardiovascular Diseases
- Others
- Global Cell and Gene Therapy Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Hospitals & Speciality Clinics
- Pharma & Biotech Companies
- Academic Research Institutes
- Others
- Global Cell and Gene Therapy Market Size & Forecast (2023-2030), Btrong>
- Introduction
- North America Cell and Gene Therapy Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Canada
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US
- Europe Cell and Gene Therapy Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (li>Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Europe
- Market Size & Foreca-user (USD Million)
- UK
- Asia Pacific (APAC) Cell and Gene Therapy Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Japan
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Asia Pacific
- China
- Latin America (LATAM) Cell and Gene Therapy Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Cell and Gene Therapy Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size &a"9">
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launch/Approval
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Sartorius AG; Novartis AG
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Charles River Laboratories
- Cell and Gene Therapy Catapult
- Lonza
- WuXi AppTec
- Takara Bio Inc.
- Bristol Myers Squibb
- FUJIFILM Holdings Corporation
- Other Prominent Players
Note: *Indicative list
**For listed companies